Mammalian adrenocorticotropic hormone receptors and uses
Abstract
The present invention relates to a mammalian adrenocorticotropic hormone receptor. The invention is directed toward the isolation, characterization and pharmacological use of mammalian adrenocorticotropic hormone receptor, the gene corresponding to this receptor, a recombinant eukaryotic expression construct capable of expressing a mammalian adrenocorticotropic hormone receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize mammalian adrenocorticotropic hormone receptor. The invention also provides for screening ACTH R agonists and antagonists in vitro using preparations of receptor from such cultures of eukaryotic cells transformed with a recombinant eukaryotic expression construct comprising the ACTH R receptor gene. The invention specifically provides human and bovine ACTH R genes.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An isolated nucleic acid encoding a mammalian adrenocorticotropic hormone receptor having an amino acid sequence that is 39% identical and co-linear, excluding the third intracellular loop and carboxy-terminal tail, to human melanocyte stimulating hormone receptor.
2 . A cell membrane preparation comprising a mammalian adrenocorticotropic hormone receptor having an amino acid sequence identified by SEQ ID NO.4 or SEQ ID NO.6 and produced by a cell that expresses a recombinant expression vector encoding the mammalian adrenocorticotropic hormone receptor.
3 . The cell membrane preparation of claim 2 , wherein the mammalian adrenocorticotropic hormone receptor has an amino acid sequence identified by SEQ ID NO.4.
4 . The cell membrane preparation of claim 2 , wherein the mammalian adrenocorticotropic hormone receptor has an amino acid sequence identified by SEQ ID NO.6.Join the waitlist — get patent alerts
Track US2003044973A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.